Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Flemming Bendtsen

Showing results (201-210 of 259) with videos related to

Pageof 26
Sort By:
American Journal of Physiology. Gastrointestinal and Liver Physiology|June 20, 2019
Cardiac dysfunction in cirrhosis: a 2-yr longitudinal follow-up study using advanced cardiac imagingSigne Wiese, Jens D Hove, Silje Mo, et al.
Plos One|May 13, 2016
Validation and Optimization of an Ex Vivo Assay of Intestinal Mucosal Biopsies in Crohn's Disease: Reflects Inflammation and Drug EffectsKasper Vadstrup, Elisabeth Douglas Galsgaard, Jens Gerwien, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 14, 2008
Infliximab for inflammatory bowel disease in Denmark 1999-2005: clinical outcome and follow-up evaluation of malignancy and mortalitySarah Caspersen, Margarita Elkjaer, Lene Riis, et al.
Journal of Hepatology|November 1, 2015
Treatment with non-selective beta blockers is associated with reduced severity of systemic inflammation and improved survival of patients with acute-on-chronic liver failureRajeshwar P Mookerjee, Marco Pavesi, Karen Louise Thomsen, et al.
Journal of Crohn'S & Colitis|March 4, 2025
Intestinal ultrasound as a prognostic tool in new-onset ulcerative colitis-a Copenhagen IBD Cohort StudyGorm Roager Madsen, Rune Wilkens, Mohamed Attauabi, et al.
Plos One|September 6, 2018
No effect of rifaximin on soluble CD163, mannose receptor or type III and IV neoepitope collagen markers in decompensated cirrhosis: Results from a randomized, placebo controlled trialNina Kimer, Natasja Stæhr Gudmann, Julie Steen Pedersen, et al.
Journal of Autoimmunity|February 16, 2021
Coronavirus disease 2019, immune-mediated inflammatory diseases and immunosuppressive therapies - A Danish population-based cohort studyMohamed Attauabi, Jakob Benedict Seidelin, Oluf Krautwald Felding, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 13, 2025
Intestinal Ultrasound Findings and Their Prognostic Value in Early Crohn's Disease: A Copenhagen IBD Cohort StudyGorm Roager Madsen, Mohamed Attauabi, Johan F K F Ilvemark, et al.
American Journal of Physiology. Endocrinology and Metabolism|January 21, 2016
Effects of endogenous GLP-1 and GIP on glucose tolerance after Roux-en-Y gastric bypass surgeryMaria S Svane, Kirstine N Bojsen-Møller, Signe Nielsen, et al.
Journal of Crohn'S & Colitis|June 30, 2026
Risk and outcome of interstitial lung disease in inflammatory bowel disease: evidence from a Danish nationwide population-based cohort studyJonas A Baekdal, Erik Sören Halvard Hansen, Howraman Meteran, et al.
Pageof 26

Showing results (201-210 of 259) with videos related to

Sort By:
Pageof 26
American Journal of Physiology. Gastrointestinal and Liver Physiology|June 20, 2019
Cardiac dysfunction in cirrhosis: a 2-yr longitudinal follow-up study using advanced cardiac imagingSigne Wiese, Jens D Hove, Silje Mo, et al.
Plos One|May 13, 2016
Validation and Optimization of an Ex Vivo Assay of Intestinal Mucosal Biopsies in Crohn's Disease: Reflects Inflammation and Drug EffectsKasper Vadstrup, Elisabeth Douglas Galsgaard, Jens Gerwien, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 14, 2008
Infliximab for inflammatory bowel disease in Denmark 1999-2005: clinical outcome and follow-up evaluation of malignancy and mortalitySarah Caspersen, Margarita Elkjaer, Lene Riis, et al.
Journal of Hepatology|November 1, 2015
Treatment with non-selective beta blockers is associated with reduced severity of systemic inflammation and improved survival of patients with acute-on-chronic liver failureRajeshwar P Mookerjee, Marco Pavesi, Karen Louise Thomsen, et al.
Journal of Crohn'S & Colitis|March 4, 2025
Intestinal ultrasound as a prognostic tool in new-onset ulcerative colitis-a Copenhagen IBD Cohort StudyGorm Roager Madsen, Rune Wilkens, Mohamed Attauabi, et al.
Plos One|September 6, 2018
No effect of rifaximin on soluble CD163, mannose receptor or type III and IV neoepitope collagen markers in decompensated cirrhosis: Results from a randomized, placebo controlled trialNina Kimer, Natasja Stæhr Gudmann, Julie Steen Pedersen, et al.
Journal of Autoimmunity|February 16, 2021
Coronavirus disease 2019, immune-mediated inflammatory diseases and immunosuppressive therapies - A Danish population-based cohort studyMohamed Attauabi, Jakob Benedict Seidelin, Oluf Krautwald Felding, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 13, 2025
Intestinal Ultrasound Findings and Their Prognostic Value in Early Crohn's Disease: A Copenhagen IBD Cohort StudyGorm Roager Madsen, Mohamed Attauabi, Johan F K F Ilvemark, et al.
American Journal of Physiology. Endocrinology and Metabolism|January 21, 2016
Effects of endogenous GLP-1 and GIP on glucose tolerance after Roux-en-Y gastric bypass surgeryMaria S Svane, Kirstine N Bojsen-Møller, Signe Nielsen, et al.
Journal of Crohn'S & Colitis|June 30, 2026
Risk and outcome of interstitial lung disease in inflammatory bowel disease: evidence from a Danish nationwide population-based cohort studyJonas A Baekdal, Erik Sören Halvard Hansen, Howraman Meteran, et al.
Pageof 26